U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H15N5O11P2
Molecular Weight 443.2005
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUANOSINE-5'-DIPHOSPHATE

SMILES

NC1=NC2=C(N=CN2[C@@H]3O[C@@H](CO[P@](O)(=O)OP(O)(O)=O)[C@H](O)[C@H]3O)C(=O)N1

InChI

InChIKey=QGWNDRXFNXRZMB-BZKDHIKHSA-N
InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6+,9+/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
5?-GDP
Preferred Name English
GUANOSINE-5'-DIPHOSPHATE
Systematic Name English
Guanosine pyrophosphate
Common Name English
Guanosine 5?-pyrophosphate
Common Name English
Guanosine 5?-(trihydrogen diphosphate)
Common Name English
((2R,3S,4R,5R)-5-(2-amino-6-hydroxy-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate
Systematic Name English
Code System Code Type Description
CAS
146-91-8
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID90163254
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY
DRUG BANK
DB04315
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY
FDA UNII
HLJ737P865
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY
WIKIPEDIA
Guanosine diphosphate
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY
PUBCHEM
6453837
Created by admin on Wed Apr 02 10:42:03 GMT 2025 , Edited by admin on Wed Apr 02 10:42:03 GMT 2025
PRIMARY